Mendelian randomization analyses (using genetic proxies for leptin) have not found a clear causal role for leptin in coronary or stroke risk (e.g., OR ≈1.48; 95% CI 0.78–2.80), suggesting leptin might be a marker of obesity rather than an independent cause [84]. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.